Abdominopelvic Fascial Release for Post-Cesarean Menstrual Pain and Scar Mobility (NCT07717983) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Abdominopelvic Fascial Release for Post-Cesarean Menstrual Pain and Scar Mobility
58 participantsStarted 2026-07-18
Plain-language summary
The goal of this randomized controlled clinical trial is to determine whether adding abdominopelvic fascial release to a standardized stretching exercise program is more effective than stretching exercises alone in reducing menstrual pain in women following cesarean section. The study will enroll women aged 20 to 35 years with moderate to severe dysmenorrhea after cesarean delivery. Researchers will compare the effects of abdominopelvic fascial release combined with stretching exercises with stretching exercises alone on menstrual pain and scar mobility. Participants will be randomly assigned to one of two treatment groups, undergo assessments before and after the intervention period, and receive the assigned treatment according to the study protocol.
Who can participate
Age range
20 Years – 35 Years
Sex
FEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Females aged 20 to 35 years.
* History of at least one cesarean section.
* Moderate to severe primary or secondary dysmenorrhea following cesarean section.
* Regular menstrual cycles (21-35 days).
* Body mass index (BMI) between 18.5 and 29.9 kg/m².
* At least 6 months post-cesarean section to allow complete scar healing.
* Presence of restricted cesarean scar mobility on clinical examination.
* Willingness to participate and provide written informed consent.
Exclusion Criteria:
* Pregnancy or planned pregnancy during the study period.
* Previous abdominal or pelvic surgery other than cesarean section.
* Endometriosis, adenomyosis, uterine fibroids requiring treatment, or other diagnosed gynecological disorders associated with pelvic pain.
* Active pelvic inflammatory disease or genitourinary infection.
* Neurological or musculoskeletal disorders affecting pain perception or mobility.
* Systemic inflammatory, autoimmune, or connective tissue diseases.
* Current participation in another physical therapy or manual therapy program targeting the abdomen or pelvis.
* Use of corticosteroid injections or other invasive treatments to the abdominal or pelvic region within the previous 3 months.
* Contraindications to manual therapy.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Change in Menstrual Pain Intensity
Timeframe: Baseline and immediately after completion of the 4-week intervention period.